Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results for PINK:RHHBY
36.22
-0.05 (-0.14%)
Apr 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 36.22 - 36.70
52 week 28.61 - 38.71
Open 36.66
Vol / Avg. 879,609.00/1.12M
Mkt cap 249.94B
P/E 19.82
Div/yield 1.11/3.06
EPS 1.83
Shares 6.90B
Beta 0.58
Inst. own 1%
Jun 26, 2014
Roche Holding AG at JPMorgan European Healthcare Conference Add to calendar
Jun 18, 2014
Roche Holding AG at Citi European Healthcare Conference Add to calendar
Jun 18, 2014
Roche Holding AG at Barclays Internationals Franchise Conference Add to calendar
Jun 10, 2014
Roche Holding AG at Goldman Sachs Healthcare Conference Add to calendar
Jun 2, 2014
Roche Holding AG at Jefferies Global Healthcare Conference Add to calendar
Jun 1, 2014
Roche Holding AG ASCO 2014 Analyst Event - 7:30PM EDT - Add to calendar
May 30, 2014
Roche Holding AG at Sanford C Bernstein Strategic Decisions Conference Add to calendar
May 21, 2014
Roche Holding AG at UBS Global Healthcare Conference Add to calendar
May 15, 2014
Roche Holding AG at Berenberg Diagnostics Conference Add to calendar
May 14, 2014
Roche Holding AG at Bank of America Merrill Lynch Health Care Conference Add to calendar
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 22.68% 24.31%
Operating margin 33.14% 34.99%
EBITD margin - 41.93%
Return on average assets 17.47% 17.91%
Return on average equity 62.66% 66.04%
Employees 81,769 -
CDP Score - 96 B

Address

Grenzacherstrasse 124
Basel, 4070
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. Pharmaceuticals are divided into two sub-divisions: Roche Pharmaceuticals and Chugai. It operates in the United States, Western Europe, Japan, CEMAI (Central and Eastern Europe, Middle East, Africa, Central Asia, Indian Subcontinent), Latin America, Asia-Pacific and Other regions. Diagnostics include five business areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Director
Age: 47
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 47
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 52
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Age: 50
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
Age: 66
John C. Reed MD, PhD Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 56
Richard H. Scheller Ph.D. Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 61
Urs Jaisli Chief Compliance Officer
Age: 58
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 60
Silvia Ayyoubi Member of the Corporate Executive Committee, Head of Group Human Resources
Age: 61